Know Cancer

or
forgot password

A Pilot Study to Examine a Novel Controlled Hypo-Perfusion Technique in Partial Nephrectomy


Phase 2
18 Years
90 Years
Open (Enrolling)
Both
Partial Nephrectomy, Renal Cell Carcinoma

Thank you

Trial Information

A Pilot Study to Examine a Novel Controlled Hypo-Perfusion Technique in Partial Nephrectomy


Inclusion Criteria:



- Patient must be at least 18 years old scheduled for open partial nephrectomy

Exclusion Criteria:

- No prior diagnosis of renal artery disease

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention

Outcome Measure:

To perfect the Renal Hypoperfusion during partial nephrectomy is feasible safe and result in better renal function than complete occlusion of renal blood flow

Outcome Description:

renal function will be measured using creatinine, eGFR, 24 hr creat clearance, and NGAL biomarker of acute kidney injury

Outcome Time Frame:

up to 2 weeks prior to surgery and up to 24 hrs post surgery

Safety Issue:

Yes

Principal Investigator

Michael Jewett, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

University Health Network, Toronto

Authority:

Canada: Ethics Review Committee

Study ID:

Hypoperfusion

NCT ID:

NCT01720693

Start Date:

June 2012

Completion Date:

December 2013

Related Keywords:

  • Partial Nephrectomy
  • Renal Cell Carcinoma
  • partial nephrectomy
  • hypoperfusion
  • renal function
  • Carcinoma
  • Carcinoma, Renal Cell

Name

Location